Compare IPCA Labs with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ALKEM LABORATORIES IPCA LABS/
ALKEM LABORATORIES
 
P/E (TTM) x 25.4 21.3 119.0% View Chart
P/BV x 4.9 4.9 101.2% View Chart
Dividend Yield % 0.4 1.0 43.9%  

Financials

 IPCA LABS   ALKEM LABORATORIES
EQUITY SHARE DATA
    IPCA LABS
Mar-21
ALKEM LABORATORIES
Mar-21
IPCA LABS/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,4563,150 78.0%   
Low Rs1,3712,224 61.7%   
Sales per share (Unadj.) Rs423.3741.4 57.1%  
Earnings per share (Unadj.) Rs90.6135.3 66.9%  
Cash flow per share (Unadj.) Rs107.1158.3 67.6%  
Dividends per share (Unadj.) Rs4.0030.00 13.3%  
Avg Dividend yield %0.21.1 18.7%  
Book value per share (Unadj.) Rs370.6616.8 60.1%  
Shares outstanding (eoy) m126.85119.57 106.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.53.6 124.7%   
Avg P/E ratio x21.119.9 106.4%  
P/CF ratio (eoy) x17.917.0 105.3%  
Price / Book Value ratio x5.24.4 118.5%  
Dividend payout %4.422.2 19.9%   
Avg Mkt Cap Rs m242,728321,244 75.6%   
No. of employees `000NANA-   
Total wages/salary Rs m10,13616,210 62.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,69988,650 60.6%  
Other income Rs m1,2922,332 55.4%   
Total revenues Rs m54,99190,982 60.4%   
Gross profit Rs m14,81219,424 76.3%  
Depreciation Rs m2,0922,746 76.2%   
Interest Rs m123589 20.8%   
Profit before tax Rs m13,89018,421 75.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4012,243 107.0%   
Profit after tax Rs m11,48816,178 71.0%  
Gross profit margin %27.621.9 125.9%  
Effective tax rate %17.312.2 142.0%   
Net profit margin %21.418.2 117.2%  
BALANCE SHEET DATA
Current assets Rs m34,37069,288 49.6%   
Current liabilities Rs m11,33136,041 31.4%   
Net working cap to sales %42.937.5 114.4%  
Current ratio x3.01.9 157.8%  
Inventory Days Days4920 248.8%  
Debtors Days Days666 8.3%  
Net fixed assets Rs m26,29534,825 75.5%   
Share capital Rs m254239 106.1%   
"Free" reserves Rs m46,76373,517 63.6%   
Net worth Rs m47,01773,756 63.7%   
Long term debt Rs m365343 106.7%   
Total assets Rs m60,664104,114 58.3%  
Interest coverage x114.232.3 354.0%   
Debt to equity ratio x00 167.4%  
Sales to assets ratio x0.90.9 104.0%   
Return on assets %19.116.1 118.8%  
Return on equity %24.421.9 111.4%  
Return on capital %29.625.7 115.3%  
Exports to sales %022.1 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA19,555 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27,17219,555 139.0%   
Fx outflow Rs m7,9492,467 322.1%   
Net fx Rs m19,22317,088 112.5%   
CASH FLOW
From Operations Rs m10,90112,649 86.2%  
From Investments Rs m-5,207-9,985 52.1%  
From Financial Activity Rs m-3,058-2,718 112.5%  
Net Cashflow Rs m2,636-17 -15,326.7%  

Share Holding

Indian Promoters % 46.3 57.1 81.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.0 19.6 224.9%  
FIIs % 11.0 5.4 203.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 42.9 125.3%  
Shareholders   115,335 81,869 140.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    

Yellow Ad

Advertisement

Our FREE Guide: Small Caps That Will Race Ahead of the Sensex

Richa Agarwal, our head of smallcap research, recently released the updated version of her very popular guide:

'Small Caps That Will Race Ahead of the Sensex':

When you sign-up for Richa's One Stock Crorepati mega summit, you get this premium guide worth Rs 950 for absolutely FREE.:

Learn more



Today's Market

SGX Nifty Down 58 Points, Why Auto Stocks are Rising, the Latest on Cryptos, and Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets rose for the third consecutive session, as prospects of a slowing economic growth fanned hopes that global central banks may go slow on interest rate hikes.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 27, 2022 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - BAL PHARMA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS